低类蛋白水平可能会加重唐氏综合征的脑部问题; 恢复它帮助了小鼠, 但人类的治疗需要数年时间. Low pleiotrophin levels may worsen brain issues in Down syndrome; restoring it helped mice, but human treatments are years away.

科学家发现脑细胞中蛋白质类蛋白的低水平可能导致唐氏综合征的神经系统的挑战. Scientists have found that low levels of the protein pleiotrophin in brain cells may contribute to neurological challenges in Down syndrome. 在小鼠中，恢复多效性营养蛋白通过增强神经连接来改善大脑功能、学习和记忆力，即使是成年人也是如此。 In mice, restoring pleiotrophin improved brain function, learning, and memory, even in adults, by enhancing neural connections. 通常由支持性天体细胞生产的蛋白质可以通过基因治疗或蛋白注入提供,提供潜在的治疗途径。 The protein, normally produced by supportive astrocytes, could be delivered via gene therapy or protein infusions, offering a potential treatment path. 该研究虽然很有希望,但尚处于早期阶段,尚不适用于人类。 While promising, the research is early-stage and not yet applicable to humans. 这项研究由NIH和Chan Zuckerberg倡议资助, 对阿尔茨海默氏综合症和脆弱的X综合症等疾病提出了更广泛的影响。 The study, funded by the NIH and Chan Zuckerberg Initiative, suggests broader implications for conditions like Alzheimer’s and fragile X syndrome.